Oncternal Therapeutics Inc (ONCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,465 | -10,340 | -5,821 | -14,194 | -9,647 |
| Depreciation Amortization | -401 | -198 | 35 | 357 | 264 |
| Accounts payable and accrued liabilities | 732 | 717 | 650 | -153 | 146 |
| Other Working Capital | 6,143 | 6,188 | 55 | 290 | 237 |
| Other Operating Activity | -58 | -283 | -400 | 703 | -63 |
| Operating Cash Flow | $-9,049 | $-3,916 | $-5,481 | $-12,997 | $-9,063 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,028 | -812 | -71 | -108 | -60 |
| Investing Cash Flow | $-1,028 | $-812 | $-71 | $-108 | $-60 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 71,403 | 71,403 | 71,403 | 1 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 18,948 | 19,986 |
| Financing Cash Flow | $71,403 | $71,403 | $71,403 | $18,949 | $19,986 |
| Beginning Cash Position | 14,769 | 14,769 | 14,769 | 8,925 | 8,925 |
| End Cash Position | 76,095 | 81,444 | 80,620 | 14,769 | 19,788 |
| Net Cash Flow | $61,326 | $66,675 | $65,851 | $5,844 | $10,863 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,049 | -3,916 | -5,481 | -12,997 | -9,063 |
| Capital Expenditure | -1,028 | -812 | -71 | -108 | -60 |
| Free Cash Flow | -10,077 | -4,728 | -5,552 | -13,105 | -9,123 |